GlobeNewsWire
03 Apr 2026, 17:30 UTC · 30w ago
Denali Therapeutics Regains Full Rights to Investigational Therapy DNL593 (PTV:PGRN) for GRN-related Frontotemporal Dementia (FTD-GRN)
Verdict
Headline takes no side. We score DNLI +0.20 — slightly bullish.
- Expected · DNLI
+0.20slightly bullish
−1 bearish0bullish +1More positive than 53% of ticker scores this week





